Nadeem Q. Mirza's most recent trade in Aprea Therapeutics Inc was a trade of 26,920 Stock Options (Right to Purchase) done . Disclosure was reported to the exchange on May 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | Nadeem Q. Mirza | Chief Medical Officer | 01 May 2024 | 26,920 | 26,920 | - | - | Stock Options (Right to Purchase) | ||
| Aprea Therapeutics Inc | Nadeem Q. Mirza | Chief Medical Officer | 01 May 2024 | 6,730 | 6,730 (0%) | 0% | 0 | Common Stock |